PATENT CLAIM ANALYSIS

Application Number: 16098546
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "235500"]

Abstract:
This application discloses compounds according to generic Formula I: wherein all variables are defined as described herein which exhibit strong inhibition effects on various cancer cell lines. The compounds disclosed herein are useful for the treatment of proliferative diseases, including neoplastic diseases such as cancer and non-neoplastic disorders such as rheumatoid arthritis. Also disclosed are pharmaceutical compositions containing compounds of Formula I and at least one carrier, diluent or excipient and optionally one or more additional therapeutically active agents, including anticancer agents. This application also discloses methods for treating a proliferative disease, including neoplastic diseases such as cancer and non-neoplastic disorders such as rheumatoid arthritis.

Claim (Index 74):
The method according to  claim 73 , wherein the neoplastic disease is cancer.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 98.0
- Lexical Diversity: 1.62857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15526983', '14777917', '14777459', '14410426', '14758194']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7608459970542369
- 35 USC 102 Novelty (BERT): 0.5357007043502153
- Combined Prediction Score: 0.7383314677838347
- Mean Citation Score: 295.124112
- Max Citation Score: 323.60352
- Similarity Product: 181.8745833561516

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test